The prime ministers of France and the United Kingdom are set to receive the AstraZeneca vaccine in opposition to coronavirus on Friday.
Both the UK’s Boris Johnson and France’s Jean Castex made the announcement on Thursday, the identical day that the EU’s medical regulatory physique deemed the Oxford-AstraZeneca shot “safe and effective.”
Plenty of EU international locations, together with France, quickly halted administering the vaccine this week. They have been involved after blood clot problems have been reported in a small variety of vaccine recipients.
“There is no reason for the French people to turn down the AstraZeneca COVID-19 vaccine,” authorities spokesman Gabriel Attal advised France’s RTL radio on Friday.
Why did international locations cease utilizing the AstraZeneca vaccine?
A complete of 13 EU member states quickly halted vaccinations with the British-Swedish shot after EU member states reported 30 instances of blood clot problems.
This included studies of a uncommon and difficult-to-treat situation known as cerebral venous thrombosis (CVT).
The studies sparked an investigation by the EU’s regulatory physique, the European Medicines Agency (EMA)
AstraZeneca vaccine is protected, stress medical regulators
After the EMA declared the AstraZeneca COVID-19 vaccine protected to be used on Thursday, several European countries including Germany, started utilizing the shot once more.
It stated that it got here to a “clear scientific conclusion” that the advantages of the vaccine far outweigh the dangers.
Emer Cooke, the manager director of the EMA, stated the AstraZeneca vaccine is a “safe and effective option to protect citizens from COVID-19.”
At the identical time, Cooke stated the EMA couldn’t “definitively rule out a link” between the vaccine and blood clots.
On Wednesday, the World Health Organization (WHO) stated that it was additionally finishing up an investigation into the blood clots in AstraZeneca vaccine recipients. But it additionally really helpful that international locations proceed to manage jabs as in addition they consider the advantages outweigh the prices.
What type of vaccine is AstraZeneca and the way does it work?
The vaccine was developed and produced by a workforce from Oxford University and the British-Swedish pharmaceutical firm AstraZeneca. The analysis workforce consists of scientists from the Jenner Institute and the Oxford Vaccine Group.
AstraZeneca’s vaccine is a vector virus vaccine. It makes use of a innocent chilly virus widespread to chimpanzees as a transport mechanism. The vaccine transports the floor protein of SARS-CoV-2 to human cells, the place it triggers an immune response in opposition to the coronavirus.
It is especially helpful as a result of it doesn’t should be saved at ultra-low temperatures, just like the BioNTech-Pfizer and Moderna vaccines. It additionally comes with a low price ticket.